NAMS vs PHG: Side-by-Side Comparison
Compare NewAmsterdam Pharma Company NV (NAMS) and Koninklijke Philips N.V. (PHG) side by side: market cap USD 4.07B vs USD 26.41B. Financials, growth and model signals on Bullrun.
| Metric | NAMS | PHG |
|---|---|---|
| Company | NewAmsterdam Pharma Company NV | Koninklijke Philips N.V. |
| Country / Exchange | Netherlands · NASDAQ | Netherlands · NYSE |
| Sector | Healthcare | Healthcare |
| Industry | Biotechnology | Medical Devices |
| Market cap | USD 4.07B | USD 26.41B |
| P/E ratio | — | 23.8 |
| Dividend yield | — | 3.65% |
| Valuation model | — | 10.4% undervalued |
| Revenue (latest FY) | USD 22.50M | — |
| Revenue growth YoY | -50.6% | — |
| Net income | USD -203.00M | — |
| Gross margin | — | — |
| Diluted EPS | -1.72 | — |